These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15703813)

  • 1. Additional Cyclin D(1) gene copies associated with chromosome 11 aberrations in cutaneous malignant melanoma.
    Utikal J; Udart M; Leiter U; Peter RU; Krähn G
    Int J Oncol; 2005 Mar; 26(3):597-605. PubMed ID: 15703813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Numerical abnormalities of the Cyclin D1 gene locus on chromosome 11q13 in non-melanoma skin cancer.
    Utikal J; Udart M; Leiter U; Kaskel P; Peter RU; Krähn G
    Cancer Lett; 2005 Mar; 219(2):197-204. PubMed ID: 15723720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases.
    Kraehn GM; Utikal J; Udart M; Greulich KM; Bezold G; Kaskel P; Leiter U; Peter RU
    Br J Cancer; 2001 Jan; 84(1):72-9. PubMed ID: 11139316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased chromosome 20 copy number detected by fluorescence in situ hybridization (FISH) in malignant melanoma.
    Barks JH; Thompson FH; Taetle R; Yang JM; Stone JF; Wymer JA; Khavari R; Guan XY; Trent JM; Pinkel D; Nelson MA
    Genes Chromosomes Cancer; 1997 Aug; 19(4):278-85. PubMed ID: 9258664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
    Mrhalová M; Kodet R; Strnad P
    Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes.
    Gerami P; Mafee M; Lurtsbarapa T; Guitart J; Haghighat Z; Newman M
    Arch Dermatol; 2010 Mar; 146(3):273-8. PubMed ID: 20231497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal oncocytomas with 11q13 rearrangements: cytogenetic, molecular, and immunohistochemical analysis of cyclin D1.
    Jhang JS; Narayan G; Murty VV; Mansukhani MM
    Cancer Genet Cytogenet; 2004 Mar; 149(2):114-9. PubMed ID: 15036886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 is a candidate oncogene in cutaneous melanoma.
    Sauter ER; Yeo UC; von Stemm A; Zhu W; Litwin S; Tichansky DS; Pistritto G; Nesbit M; Pinkel D; Herlyn M; Bastian BC
    Cancer Res; 2002 Jun; 62(11):3200-6. PubMed ID: 12036934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletions of the region 17p11-13 in advanced melanoma revealed by cytogenetic analysis and fluorescence in situ hybridization.
    Okamoto I; Pirc-Danoewinata H; Ackermann J; Drach J; Schlagbauer Wadl H; Jansen B; Wolff K; Pehamberger H; Marosi C
    Br J Cancer; 1999 Jan; 79(1):131-7. PubMed ID: 10408704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of DNA flow cytometry and fluorescence in situ hybridization using a chromosome-specific DNA probe on paraffin-embedded tissue sections of primary malignant melanomas.
    Matsuta M; Imamura Y; Matsuta M; Kon S; Sasaki K
    J Dermatol; 1994 Jan; 21(1):14-9. PubMed ID: 8157816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions.
    Saiz AD; Olvera M; Rezk S; Florentine BA; McCourty A; Brynes RK
    J Pathol; 2002 Oct; 198(2):157-62. PubMed ID: 12237874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 expression in melanocytic lesions of the skin.
    Ramirez JA; Guitart J; Rao MS; Diaz LK
    Ann Diagn Pathol; 2005 Aug; 9(4):185-8. PubMed ID: 16084449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and distribution of trisomy 11 in multiple myeloma patients: relation with overexpression of CCND1 and t(11;14).
    Guglielmelli T; Giugliano E; Cappia S; Papotti M; Saglio G
    Cancer Genet Cytogenet; 2007 Feb; 173(1):51-6. PubMed ID: 17284370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in chromosomal aberrations between nodular and superficial spreading malignant melanoma detected by interphase cytogenetics.
    Poetsch M; Woenckhaus C; Dittberner T; Pambor M; Lorenz G; Herrmann FH
    Lab Invest; 1998 Jul; 78(7):883-8. PubMed ID: 9690566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastasis suppressed, but tumorigenicity and local invasiveness unaffected, in the human melanoma cell line MelJuSo after introduction of human chromosomes 1 or 6.
    Miele ME; Robertson G; Lee JH; Coleman A; McGary CT; Fisher PB; Lugo TG; Welch DR
    Mol Carcinog; 1996 Apr; 15(4):284-99. PubMed ID: 8634087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific dermoscopy patterns and amplifications of the cyclin D1 gene to define histopathologically unrecognizable early lesions of acral melanoma in situ.
    Yamaura M; Takata M; Miyazaki A; Saida T
    Arch Dermatol; 2005 Nov; 141(11):1413-8. PubMed ID: 16301388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.
    Gerami P; Wass A; Mafee M; Fang Y; Pulitzer MP; Busam KJ
    Am J Surg Pathol; 2009 Dec; 33(12):1783-8. PubMed ID: 19809275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vivo modulatory effects of an anterior-chamber microenvironment on uveal melanoma.
    Mudhar HS; Saunders E; Rundle P; Rennie IG; Sisley K
    Br J Ophthalmol; 2009 Apr; 93(4):535-40. PubMed ID: 19019926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A malignant melanoma tumor suppressor on human chromosome 11.
    Robertson G; Coleman A; Lugo TG
    Cancer Res; 1996 Oct; 56(19):4487-92. PubMed ID: 8813145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
    Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
    Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.